LCBSX
Price
$50.41
Change
-$0.06 (-0.12%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

LCBSX vs RPTIX

Header iconLCBSX vs RPTIX Comparison
Open Charts LCBSX vs RPTIXBanner chart's image
ClearBridge Select FI
Price$50.41
Change-$0.06 (-0.12%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LCBSX vs RPTIX Comparison Chart
Loading...
VS
LCBSX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCBSX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. LCBSX (3.33B). RPTIX pays higher dividends than LCBSX: RPTIX (0.18) vs LCBSX (0.00). LCBSX was incepted earlier than RPTIX: LCBSX (12 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. LCBSX (20.00). LCBSX has a lower initial minimum investment than RPTIX: LCBSX (0) vs RPTIX (500000). LCBSX annual gain was more profitable for investors over the last year : 28.29 vs. RPTIX (14.81). LCBSX return over 5 years is better than : 84.40 vs. RPTIX (15.09).
LCBSXRPTIXLCBSX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years9 years-
Gain YTD13.6469.127150%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.33B31.4B11%
Annual Yield % from dividends0.000.18-
Returns for 1 year28.2914.81191%
Returns for 3 years-8.85-13.5765%
Returns for 5 years84.4015.09559%
Returns for 10 years238.27N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp